Nicardipine inhibits N-type calcium channels in dbcAMP-differentiated neuroblastoma x glioma hybrid cells (NG 108-15 cells)

Zhongguo Yao Li Xue Bao. 1999 Feb;20(2):117-20.

Abstract

Aim: To investigate the possibility of dihydropyridine inhibition of N-type calcium channels.

Methods: Effects of nifedipine and nicardipine on the high K(+)-induced intracellular Ca2+ concentration ([Ca2+]i) increase were studied by measuring [Ca2+]i using the fluorescent indicator Fura-2.

Results: Pretreatment of cells with nifedipine 50 mumol.L-1 inhibited the high K(+)-induced [Ca2+]i transient by about 60% (n = 3); however, pretreatment of cells with nicardipine 10 mumol.L-1 completely prevented the high K(+)-evoked [Ca2+]i increase in dibutyryl cyclic AMP (dbcAMP)-differentiated NG 108-15 cells (n = 5). The high K(+)-induced [Ca2+]i increase was mediated by L- and N-type voltage-sensitive calcium channels (VSCC) in NG 108-15 cells.

Conclusion: Nicardipine at micromolar range inhibited both L- and N-type VSCC in dbcAMP-differentiated NG 108-15 cells whereas nifedipine mainly inhibited L-type calcium channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bucladesine
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects*
  • Cell Transformation, Neoplastic / drug effects
  • Glioma / pathology
  • Humans
  • Hybrid Cells
  • Neuroblastoma / pathology
  • Nicardipine / pharmacology*
  • Nifedipine / pharmacology
  • Tumor Cells, Cultured / drug effects

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Bucladesine
  • Nicardipine
  • Nifedipine